Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anthrax Vaccine Adsorbed Injectable Suspension [Biothrax]

National Institutes of Health

Related topics

Related topics

2 relations
BiothraxInjectable Suspension

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillusanthracis spore inhalation challenge
Anthrax is a serious biological threat caused by pulmonary exposure to aerosolized spores of Bacillus anthracis. Biothrax… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2016
Review
2016
Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule
ABSTRACT Introduction: The availability of a licensed anthrax vaccine that is safe, effective, and easy to administer for both… Expand
2013
2013
BIOTHRAX ® (ANTHRAX VACCINE ADSORBED) FOR POST-
2 ABSTRACT 14 Antimicrobials administered post-exposure can reduce the incidence or progression of anthrax 15 
Review
2009
Review
2009
Anthrax Vaccine: A Dilemma for Homeland Security
Past problems with the Department of Defense anthrax vaccine currently impact national emergency response plans approved by the… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE